Efficacy and safety of an intravenous induction therapy for treatment of disseminated Mycobacterium avium complex infection in AIDS patients: A pilot study

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 1, 1999, Pages 129-131

  Roger, Pierre Marie ^a   Carles, Michel ^a   Agussol Foin, Isabelle ^a   Pandiani, Liliana ^b   Keïta Perse, Olivia ^a   Mondain, Veronique ^a   De Salvador, Francine ^a   Dellamonica, Pierre ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Labaratoire Marcel Merieux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ETHAMBUTOL; MACROLIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; ORAL DRUG ADMINISTRATION; RELAPSE; SIDE EFFECT;

ADMINISTRATION, ORAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INFUSIONS, INTRAVENOUS; MACROLIDES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PILOT PROJECTS;

EID: 0032816572     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.1.129     Document Type: Article

References (7)

1. Shafran, S. D., Singer, J., Zarowny, D., Phillips, P., Salit, I., Walmsley, S. L. et al. (1996). A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. New England Journal of Medicine 335, 377-83.
2. Heifets, L. (1996). Susceptibility testing of Mycobacterium avium complex isolates. Antimicrobial Agents and Chemotherapy 40, 1759-67.
3. Chiu, J., Nussbaum, J., Bozette, S., Tilles, J. G., Young, L. S., Leedom, J. et al. (1990). Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin and ciprofloxacin. Annals of Internal Medicine 113, 358-61.
4. Gordon, S. M., Horsburgh, C. R., Peloquin, C. A., Havlik, J. A., Metchock, B., Heifets, L. et al. (1993). Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. Journal of Infectious Diseases 168, 1559-62.
5. Jacobson, M. A. & French, M. (1998). Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 12, Suppl. A, S157-63.
6. De Lalla, F., Maserati, R., Scarpellini, P., Marone, P., Nicolin, R., Caccamo F. et al. (1992). Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrobial Agents and Chemotherapy 36, 1567-9.
7. Bermudez, L. E., Nash, K. A., Petrofsky, M., Young, L. S. & Inderlied, C. B. (1996). Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. Journal of Infectious Diseases 174, 1218-22.